Filing Analysis
Solesence, Inc. filed a Form 8-K on May 12, 2026, to announce its results of operations and financial condition. The filing includes a press release as Exhibit 99.1, which is standard for quarterly or annual earnings announcements.
📋 Key Facts
- The filing was made under Item 2.02 (Results of Operations and Financial Condition).
- A press release dated May 12, 2026, was included as Exhibit 99.1.
- The document was signed by Chief Financial Officer Laura Riffner.
- The company is listed on the NASDAQ Capital Market under the ticker symbol SLSN.
Solesence, Inc. has appointed Marc James to its Board of Directors as a Class II Director, effective April 24, 2026. Mr. James will serve on the Audit and Finance, Compensation, and Nominating and Corporate Governance committees.
📋 Key Facts
- Marc James was appointed as a Class II Director effective April 24, 2026.
- The term for this position expires at the 2026 Annual Meeting of Shareholders.
- Mr. James was appointed to three committees: Audit and Finance, Compensation, and Nominating and Corporate Governance.
- The filing was signed by CFO Laura Riffner on April 28, 2026.
Solesence, Inc. filed an 8-K on March 31, 2026, to report its results of operations and financial condition via a press release. This is a routine disclosure of financial performance for the period ending March 31, 2026.
📋 Key Facts
- The filing was made under Item 2.02: Results of Operations and Financial Condition.
- A press release dated March 31, 2026, was included as Exhibit 99.1.
- The report was signed by Laura Riffner, Chief Financial Officer.
- The company is incorporated in Delaware and listed on The NASDAQ Capital Market under the symbol SLSN.